Billing and Coding: MolDX: HLA-DQB1*06:02 Testing for Narcolepsy

This document (A57465) is coding and billing guidance for HLA-DQB1*06:02 testing related to narcolepsy and is intended to be used with its associated Local Coverage Determination. The policy text provided contains no specific clinical indications, exclusions, documentation, or frequency limits—those details must be obtained from the associated LCD and require manual review.

"This policy provides coding and billing guidance for HLA-DQB1*06:02 testing performed in the evaluation of suspected narcolepsy; refer to the associated Local Coverage Determination (LCD) for speci..."

Sign up to see full coverage criteria, indications, and limitations.